<HTML>
<HEAD>
<TITLE>sv8</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt">As filed with the Securities and Exchange Commission on October&nbsp;12, 2010.
</DIV>


<DIV align="right" style="font-size: 10pt; margin-top: 6pt">Registration No.&nbsp;333-&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</DIV>


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM S-8</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>REGISTRATION STATEMENT<BR>
UNDER<BR>
THE SECURITIES ACT OF 1933</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><DIV align="center"><DIV style="FONT-size: 3pt; margin-top: 16pt; width: 26%; border-top: 1px solid #000000">&nbsp;</DIV></DIV></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>DEX ONE CORPORATION</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top">Delaware
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">13-2740040</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(I.R.S. Employer Identification No.)</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">1001 Winstead Drive, Cary, NC
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">27513</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(zip code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Employment Agreement with Alfred Mockett<BR>
(Full title of the Plan)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Mark W. Hianik<BR>
Senior Vice President, General Counsel and Corporate Secretary<BR>
Dex One Corporation<BR>
1001 Winstead Drive<BR>
Cary, NC 27513<BR>
(Name and address of agent for service)</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">(919)&nbsp;297-1600<BR>
(Telephone number, including area code, of agent for service)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of &#147;large accelerated
filer,&#148; &#147;accelerated filer&#148; and &#147;smaller reporting company&#148; in Rule&nbsp;12b-2 of the Exchange Act.
(Check one):
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
</TR>
<TR></TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><FONT style="white-space: nowrap">Large Accelerated Filer <FONT style="font-family: Wingdings">&#111;</FONT></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">Accelerated Filer <FONT style="font-family: Wingdings">&#111;</FONT></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">Non-Accelerated Filer <FONT style="font-family: Wingdings">&#254;</FONT></FONT>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">Smaller Reporting Company <FONT style="font-family: Wingdings">&#111;</FONT></FONT></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><FONT style="white-space: nowrap">(Do not check if a smaller reporting company)</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Calculation of Registration Fee</B></DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom" style="font-siz: 1px">
    <TD width="1%"></TD>
    <TD width="32%"></TD>
    <TD width="2%"></TD><!-- VRule -->
    <TD width="2%"></TD>
    <TD width="14%"></TD>
    <TD width="2%"></TD><!-- VRule -->
    <TD width="2%"></TD>
    <TD width="8%"></TD>
    <TD width="2%"></TD><!-- VRule -->
    <TD width="2%"></TD>
    <TD width="16%"></TD>
    <TD width="2%"></TD><!-- VRule -->
    <TD width="2%"></TD>
    <TD width="12%"></TD>

    <TD width="1%"></TD>
</TR><TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-bottom: 3px double #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Proposed</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Proposed</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center">Title of</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">maximum</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">maximum</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center">securities to be</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Amount to be</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">offering price</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">aggregate</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">Amount of</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">    <TD width="1%">&nbsp;</TD>

    <TD nowrap align="center">registered</TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">registered <SUP style="FONT-size: 85%; vertical-align: text-top">(1) </SUP></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">per share <SUP style="FONT-size: 85%; vertical-align: text-top">(4)</SUP></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">offering price<SUP style="FONT-size: 85%; vertical-align: text-top"> (4)</SUP></TD>
    <TD style="border-right: 2px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">registration fee</TD>
    <TD width="1%">&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
                    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, par
value $0.001 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">200,000<SUP style="FONT-size: 85%; vertical-align: text-top">(2)</SUP></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$10.775</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$2,155,000</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$153.65</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, par
value $0.001 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">200,000<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$9.75</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$1,950,000</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$139.00</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, par
value $0.001 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">200,000<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$15.00</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$3,000,000</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$214.00</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, par
value $0.001 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">200,000<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$23.00</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$4,600,000</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$328.00</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px">Common Stock, par
value $0.001 per
share</DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">200,000<SUP style="FONT-size: 85%; vertical-align: text-top">(3)</SUP></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$32.00</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">$6,400,000</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>

<TD align="center" valign="bottom" style="border-top: 2px solid #000000">$456.00</TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000"><DIV style="margin-left:15px; text-indent:-15px"><B>Total</B></DIV></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000"><B>1,000,000</B></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000"><B>$18,105,000</B></TD>
    <TD style="border-right: 2px solid #000000; border-top: 2px solid #000000">&nbsp;</TD>
    <TD style="border-top: 2px solid #000000">&nbsp;</TD>
    <TD align="center" valign="bottom" style="border-top: 2px solid #000000"><B>$1,290.65</B></TD>
    <TD width="1%" style="border-top: 2px solid #000000">&nbsp;</TD>
</TR>
<TR style="font-size: 1px" valign="bottom">
    <TD nowrap align="left" colspan="15" style="border-top: 3px double #000000">&nbsp;</TD>
</TR>

<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left">
<DIV style="font-size: 0pt; margin-top: 3pt; width: 18%; border-top: 0px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Pursuant to Rule&nbsp;416 under the Securities Act of 1933 (the &#147;Securities Act&#148;), this
Registration Statement shall include any additional shares of common stock, par value $0.001 per
share (the &#147;Common Stock&#148;), that may become issuable as a result of stock splits, stock dividends,
recapitalizations or other similar transactions.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents 200,000 shares of our common stock to be issued as restricted stock under the
Employment Agreement with Alfred Mockett (&#147;Employment Agreement&#148;).</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(3)</TD>
    <TD>&nbsp;</TD>
    <TD>Represents 200,000 shares of our common stock underlying stock options currently
outstanding under the Employment Agreement.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(4)</TD>
    <TD>&nbsp;</TD>
    <TD>Estimated solely for the purpose of calculating the amount of the registration fee
pursuant to Rule 457(h) under the Securities Act. The price per share and aggregate offering price
are calculated on the basis of (a) $10.775, the average of the high and low sale prices of our
common stock on the New York Stock Exchange on October&nbsp;8, 2010, in accordance with Rule 457(c)
under the Securities Act, as amended, for 200,000 shares of our common stock to be issued as
restricted stock under the Employment Agreement, (b) $9.75, the exercise price of 200,000 shares of
our common stock underlying outstanding options granted under the Employment Agreement, (c) $15.00,
the exercise price of 200,000 shares of our common stock underlying outstanding options granted
under the Employment Agreement, (d) $23.00, the exercise price of 200,000 shares of our common
stock underlying outstanding options granted under the Employment Agreement, and (e) $32.00, the
exercise price of 200,000 shares of our common stock underlying outstanding options granted under
the Employment Agreement.</TD>
</TR>

</TABLE>



<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>













<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">










<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART I</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;1. Plan Information</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dex One Corporation (&#147;we&#148;, &#147;us&#148;, &#147;the Company&#148; or &#147;Dex One&#148;) entered into an employment
agreement with Alfred T. Mockett on September&nbsp;6, 2010 (the &#147;Employment Agreement&#148;). The documents
containing the information specified in Part&nbsp;I will be delivered in accordance with Form S-8 and
Rule 428(b) under the Securities Act. Such documents are not required to be, and are not, filed
with the Securities and Exchange Commission (the &#147;Commission&#148;), either as part of this Registration
Statement or as prospectuses or prospectus supplements pursuant to Rule&nbsp;424 under the Securities
Act. These documents, and the documents incorporated by reference in this Registration Statement
pursuant to Item&nbsp;3 of Part&nbsp;II of this Form S-8, taken together, constitute a prospectus that meets
the requirements of Section 10(a) of the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2. Registrant Information and Employee Plan Annual Information.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The written statement required by Item&nbsp;2 of Part&nbsp;I will be included in documents to be
delivered to Mr.&nbsp;Mockett pursuant to Rule 428(b) of the Securities Act.
</DIV>






<P align="center" style="font-size: 10pt"><!-- Folio -->I-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>REOFFER PROSPECTUS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>DEX ONE CORPORATION<BR>
200,000 SHARES OF COMMON STOCK</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This prospectus relates to the resale, from time to time, of up to 200,000 shares of our
common stock, $0.001 par value per share, by the selling stockholder listed in this prospectus. The
selling stockholder acquired such shares pursuant to grants made under the employment agreement
dated as of September&nbsp;6, 2010, between Dex One Corporation and Alfred T. Mockett (the &#147;Employment
Agreement&#148;).
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be offered, from time to time, by the selling stockholder through ordinary
brokerage transactions, in negotiated transactions or in other transactions, at such prices as he
may determine, which may relate to market prices prevailing at the time of sale or be a negotiated
price. See &#147;Plan of Distribution.&#148; We will bear all costs, expenses and fees in connection with the
registration of the shares. Brokerage commissions and similar selling expenses, if any,
attributable to the offer or sale of the shares will be borne by the selling stockholder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by the selling stockholder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The selling stockholder and any broker executing selling orders on behalf of the selling
stockholder may be deemed to be an &#147;underwriter&#148; as defined in the Securities Act of 1933, as
amended (the &#147;Securities Act&#148;). If any broker-dealers are used to effect sales, any commissions
paid to broker-dealers and, if broker-dealers purchase any of the shares of common stock covered by this
prospectus as principals, any profits received by such broker-dealers on the resales of shares may
be deemed to be underwriting discounts or commissions under the Securities Act. In addition, any
profits realized by the selling stockholder may be deemed to be underwriting commissions.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares of our common stock are listed on the New York Stock Exchange under the symbol &#147;DEXO.&#148;
On October&nbsp;8, 2010, the last reported sale price of our common stock was $10.98 per share.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Investing in shares of our common stock involves a high degree of risk. See &#147;Risk Factors&#148; on
page 2 of this prospectus and the other risk factors set forth in our periodic and other filings
with the Securities and Exchange Commission (the &#147;SEC&#148;), including those set forth in our Annual
Report on </B><B>Form 10-K</B><B> for the year ended December&nbsp;31, 2009, for a discussion of certain factors that
should carefully be considered by prospective purchasers.</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Neither the SEC nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt">This prospectus is dated October&nbsp;12, 2010.
</DIV>




<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">




<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>TABLE OF CONTENTS</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="88%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Page</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Prospectus Summary</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">1</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Forward-Looking Statements</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">1</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Risk Factors</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Use of Proceeds</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Selling Stockholder</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">2</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Plan of Distribution</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">4</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Legal Matters</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">4</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Experts</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">4</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Available Information</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">5</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Information Incorporated by Reference</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">5</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;You should rely only on the information contained in or incorporated by reference into this
prospectus. We have not authorized any other person to provide you with additional information or
information different from that contained in or incorporated by reference into this prospectus. The
selling
stockholder may, from time to time, offer to sell shares of our common stock only in jurisdictions
where the offer or sale is permitted. You should not assume that the information contained in this
prospectus is accurate as of any date other than the date on the front cover of this prospectus or
that the information contained in any document incorporated by reference into this prospectus is
accurate as of any date other than the date of the document incorporated by reference.
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PROSPECTUS SUMMARY</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>This summary highlights information contained elsewhere in or incorporated by reference into
this prospectus. This summary is not complete and does not contain all of the information that may
be important to you and that you should consider before investing in shares of our common stock.
You should carefully read the entire prospectus, including the section titled &#147;Risk Factors,&#148; and
the other information incorporated by reference into this prospectus before making an investment
decision.
References in this prospectus to the terms &#147;Dex,&#147;Dex One,&#148; &#147;the Company,&#148; &#147;we,&#148; &#147;us&#148; and &#147;our,&#148; or
other similar terms, mean Dex One Corporation, together with its consolidated subsidiaries, unless
the context indicates otherwise.</I>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Dex One Corporation</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We are a marketing solutions company that helps local businesses grow by providing marketing
products that help them get found by ready-to-buy consumers and marketing services that help them
get chosen over their competitors. Through our Dex<SUP style="FONT-size: 85%; vertical-align: text-top">&#174;</SUP> Advantage, clients&#146; business information is
published and marketed through a single profile and distributed via a variety of both owned and
operated products and through other local search products. Dex Advantage spans multiple media
platforms for local advertisers including print with our Dex published directories, which we
co-brand with other brands in the industry such as Qwest, CenturyLink and AT&#038;T, online and mobile
devices with DexKnows.com<SUP style="FONT-size: 85%; vertical-align: text-top">&#174;</SUP> and voice-activated directory search at 1-800-Call-Dex&#153;. Our digital
affiliate provided solutions are powered by DexNet&#153;, which leverages network partners including the
premier search engines, such as Google<SUP style="FONT-size: 85%; vertical-align: text-top">&#174;</SUP> and Yahoo!<SUP style="FONT-size: 85%; vertical-align: text-top">&#174;</SUP> and other leading online sites. Our growing
list of marketing services include local business and market analysis, message and image creation,
target market identification, advertising and digital profile creation, keyword and search engine
optimization strategies and programs, distribution strategies, social strategies, and tracking and
reporting.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our principal executive offices are located at 1001 Winstead Drive, Cary, North Carolina
27513, our telephone number is (919)&nbsp;297-1600 and our website address is www.dexone.com.
Information contained on our website is not a part of this prospectus.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>FORWARD-LOOKING STATEMENTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain statements contained or incorporated by reference in this Registration Statement on
Form S-8 regarding Dex One&#146;s future operating results, performance, business plans or prospects and
any other statements not constituting historical fact are &#147;forward-looking statements&#148; subject to
the safe harbor created by the Private Securities Litigation Reform Act of 1995. Where possible,
words such as &#147;believe,&#148; &#147;expect,&#148; &#147;anticipate,&#148; &#147;should,&#148; &#147;will,&#148; &#147;would,&#148; &#147;planned,&#148; &#147;estimated,&#148;
&#147;potential,&#148; &#147;goal,&#148; &#147;outlook,&#148; &#147;may,&#148; &#147;predicts,&#148; &#147;could,&#148; or the negative of those words and
other comparable expressions, are used to identify such forward-looking statements. All
forward-looking statements reflect our current beliefs and assumptions with respect to our future
results, business plans and prospects, based on information currently available to us and are
subject to significant risks and uncertainties. Accordingly, these statements are subject to
significant risks and uncertainties and our actual results, business plans and prospects could
differ significantly from those expressed in, or implied by, these statements. We caution readers
not to place undue reliance on, and we undertake no obligation to update, other than as imposed by
law, any forward-looking statements. Such risks, uncertainties and contingencies include, but are
not limited to, statements about Dex One&#146;s future financial and operating results, our plans,
objectives, expectations and intentions and other statements that are not historical facts. The
following factors, among others, could cause actual results to differ from those set forth in the
forward-looking statements: (1)&nbsp;changes in directory advertising spend and consumer usage; (2)
competition and other economic
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">conditions; (3)&nbsp;our ability to generate sufficient cash to service our debt; (4)&nbsp;our
ability to comply with the financial covenants contained in our debt agreements and the potential
impact to operations and liquidity as a result of restrictive covenants in such debt agreements;
(5)&nbsp;our ability to refinance or restructure our debt on reasonable terms and conditions as might be
necessary from time to time; (6)&nbsp;increasing LIBOR rates; (7)&nbsp;regulatory and judicial rulings; (8)
changes in the Company&#146;s and the Company&#146;s subsidiaries credit ratings; (9)&nbsp;changes in accounting
standards; (10)&nbsp;adverse results from litigation, governmental investigations or tax related
proceedings or audits; (11)&nbsp;the effect of labor strikes, lock-outs and negotiations; (12)
successful realization of the expected benefits of acquisitions, divestitures and joint ventures;
(13)&nbsp;the continued enforceability of the commercial agreements with Qwest, CenturyLink and AT&#038;T;
(14)&nbsp;our reliance on third-party vendors for various services; and (15)&nbsp;other events beyond our
control that may result in unexpected adverse operating results. Additional risks and uncertainties
are described in detail in Part&nbsp;I &#151; Item&nbsp;1A, &#147;Risk Factors&#148; of our most recent annual report on
Form 10-K.
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>RISK FACTORS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Our business is subject to uncertainties and risks. You should carefully consider and evaluate
all of the information included and incorporated by reference in this prospectus, including the
risk factors incorporated by reference from our most recent annual report on Form 10-K, as updated
by our subsequent quarterly reports on Form 10-Q and other filings we make with the SEC. It is
possible that our business, financial condition, liquidity or results of operations could be
materially adversely affected by any of these risks.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>USE OF PROCEEDS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will not receive any of the proceeds from the sale of the shares offered by this
prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will pay all expenses in connection with the registration of shares, other than commissions
and discounts of underwriters, dealers or agents.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SELLING STOCKHOLDER</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares offered by this prospectus are being registered for reoffers and resales by the
selling stockholder, who has acquired such shares pursuant to a grant of restricted stock. The
selling stockholder named below may resell all, a portion or none of such shares from time to time.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The table below sets forth, with respect to the selling stockholder, based upon information
available to us as of October&nbsp;8, 2010, the number of shares of common stock beneficially owned
before and after the sale of the shares offered by this prospectus; the number of shares to be
sold; and the percent of the outstanding shares of common stock owned before and after the sale of the common
stock offered by this prospectus.
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Number of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Percentage</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Number of </B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Percentage</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Number of</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B> Shares Owned</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B> of Shares</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Shares</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B> of Shares</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B> Shares to</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>After</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Owned After</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center"><B>Selling Stockholder</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B> Owned </B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(1)</B></SUP></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B> Owned</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>be Offered</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Offering</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(2)</B></SUP></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Offering</B><SUP style="FONT-size: 85%; vertical-align: text-top"><B>(2)</B></SUP></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR style="font-size: 1px">
    <TD colspan="21" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Alfred T. Mockett</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">200,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">*</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">200,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">0</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">0</TD>
    <TD nowrap>%</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">(Chief Executive
Officer and
President)</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">



<DIV align="left">
<DIV style="font-size: 3pt; margin-top: 16pt; width: 18%; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV>

<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">
<TR>
    <TD width="3%"></TD>
    <TD width="1%"></TD>
    <TD width="96"></TD>
</TR>

<TR valign="top">
    <TD nowrap align="left">*</TD>
    <TD>&nbsp;</TD>
    <TD>Represents less than 1% of the issued and outstanding common stock.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(1)</TD>
    <TD>&nbsp;</TD>
    <TD>Dex One Corporation and Alfred T. Mockett are parties to an employment agreement dated as of
September&nbsp;6, 2010, pursuant to which we agreed to employ Mr.&nbsp;Mockett as our Chief Executive
Officer and President. Pursuant to this agreement, Mr.&nbsp;Mockett was granted 200,000 shares of
the Company&#146;s common stock in the form of a restricted stock award, a fair market value option
to purchase 200,000 shares of the Company&#146;s common stock, and fully vested premium priced
options to purchase 600,000 shares of the Company&#146;s common stock. The 200,000 share restricted
stock award vests in three equal annual installments on each anniversary of September&nbsp;13,
2010. This summary of Mr.&nbsp;Mockett&#146;s employment agreement is qualified in its entirety by
reference to Current Report on Form 8-K filed by us on September&nbsp;9, 2010.</TD>
</TR>

<TR style="font-size: 3pt"><TD>&nbsp;</TD></TR>

<TR valign="top">
    <TD nowrap align="left">(2)</TD>
    <TD>&nbsp;</TD>
    <TD>Assumes that the selling stockholder disposes of all the shares of common stock covered by
this prospectus, and does not acquire beneficial ownership of any additional shares. The
registration of these shares does not necessarily mean that the selling stockholder will sell all
or any portion of the shares covered by this prospectus.</TD>
</TR>

</TABLE>


<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">






<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PLAN OF DISTRIBUTION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The shares may be sold or transferred for value by the selling stockholder, or by pledgees,
donees, transferees or other successors in interest to the selling stockholder, in one or more
transactions on the New York Stock Exchange, in negotiated transactions or in a combination of such
methods of sale, at market prices prevailing at the time of sale, at prices related to such
prevailing market prices or at prices otherwise negotiated. The selling stockholder may effect such
transactions by selling the shares to or through broker-dealers, and such broker-dealers may
receive compensation in the form of underwriting discounts, concessions or commissions from the
selling stockholder and/or the purchasers of the shares for whom such broker-dealers may act as
agent (which compensation may be less than or in excess of customary commissions). The selling
stockholder, and any broker-dealers that participate in the distribution of the shares, may be
deemed to be &#147;underwriters&#148; within the meaning of Section&nbsp;2(11) of the Securities Act, and any
commissions received by them and any profit on the resale of the shares sold by them may be deemed
to be underwriting discounts and commissions under the Securities Act. All
selling and other expenses incurred by individual selling stockholder will be borne by the selling
stockholder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Upon our being notified by the selling stockholder that any material arrangement has been
entered into with a broker or dealer for the sale of shares through a secondary distribution, or a
purchase by a broker or dealer, we will file a prospectus supplement, if required, pursuant to Rule
424(b) under the
Securities Act, disclosing (a)&nbsp;the name of each of such selling stockholder and the participating
broker-dealers, (b)&nbsp;the number of shares involved, (c)&nbsp;the price at which such shares are being
sold, (d)&nbsp;the commissions paid or the discounts or concessions allowed to such broker-dealers, (e)
where applicable, that such broker-dealers did not conduct any investigation to verify the
information set out or incorporated by reference in the prospectus, as supplemented, and (f)&nbsp;other
facts material to the transaction.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to any such number of shares sold hereunder, the selling stockholder may, at the
same time, sell any shares of common stock, including the shares offered by this prospectus, owned
by such person in compliance with all of the requirements of Rule&nbsp;144 under the Securities Act,
regardless of
whether such shares are covered by this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;There is no assurance that the selling stockholder will sell any or all of the shares offered
by this prospectus.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>LEGAL MATTERS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The validity of the shares of common stock offered by this prospectus has been passed upon for
Dex One by Mark W. Hianik, the Company&#146;s General Counsel.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>EXPERTS</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The consolidated financial statements of R.H. Donnelley Corporation (the predecessor to Dex
One) and subsidiaries as of December&nbsp;31, 2009 and 2008 and for each of the years in the three year
period ended December&nbsp;31, 2009 and management&#146;s assessment of the effectiveness of internal control
over financial reporting, which is included in Management&#146;s Report on Internal Control over
Financial Reporting, have been incorporated in this Prospectus by reference to the Annual Report on
Form 10-K for the year ended December&nbsp;31, 2009 in reliance upon the reports of KPMG LLP,
independent registered public accounting firm, incorporated by reference herein, and upon the
authority of said firm as experts in accounting and auditing.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>AVAILABLE INFORMATION</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We file annual, quarterly and current reports, proxy statements and other information with the
Commission. You may read and copy any reports, statements or other information that we file with
the Commission at the Commission&#146;s Public Reference Room located at 100 F Street, N.E., Washington,
D.C. 20549. Please call the Commission at l-800-SEC-0330 for further information about the
operation of the Public Reference Room. Our public filings are also available from commercial
document retrieval services and at the Internet web site maintained by the Commission at
http://www.sec.gov. We distribute to our stockholders annual reports containing audited financial
statements.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>DOCUMENTS INCORPORATED BY REFERENCE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Commission allows us to &#147;incorporate by reference&#148; information into this prospectus, which
means that we can disclose important information to investors by referring them to another document
filed separately with the Commission. The information incorporated by reference is deemed to be
part of
this prospectus, except for any information superseded by information contained directly in this
document. This prospectus incorporates by reference the documents set forth below that we have
previously filed with the Commission. These documents contain important information about us and
our financial condition.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">We incorporate by reference the documents listed below:
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(a)&nbsp;Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2009, filed with the
Commission on March&nbsp;12, 2010;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(b)&nbsp;Quarterly Reports on Form 10-Q for the fiscal quarters ended March&nbsp;31, 2010, filed with
the Commission on May&nbsp;13, 2010, and June&nbsp;30, 2010, filed with the Commission on August&nbsp;11,
2010;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(c)&nbsp;Current Reports on Form 8-K filed with the Commission on January&nbsp;15, 2010, February&nbsp;4,
2010, May&nbsp;21, 2010, August&nbsp;2, 2010, September&nbsp;9, 2010 and September&nbsp;17, 2010; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(d)&nbsp;The description of our common stock contained in Item&nbsp;1 of our Registration Statement on
Form 8-A (File No.&nbsp;001-07155) filed with the Commission on January&nbsp;20, 2010 and any
amendments to such Registration Statement filed subsequently thereto, including all
amendments or reports filed for the purpose of updating such description.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise indicated, all documents we file with the Commission pursuant to Sections
13(a), 13(c), 14, and 15(d) of the Exchange Act (other than Current Reports on Form 8-K furnished
pursuant to Item&nbsp;2.02 or Item&nbsp;7.01 of Form 8-K, including any exhibits included with such
information, unless otherwise indicated therein) subsequent to the date of this prospectus shall be
deemed to be incorporated by reference in this prospectus and to be a part of this prospectus from
the date of filing of such documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any statement contained in a previously filed document incorporated by reference in this
prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the
extent that a statement in this prospectus modifies or supersedes such previous statement and any
statement contained in this prospectus shall be deemed to be modified or superseded to the extent
that a statement in any document subsequently filed, which is incorporated by reference in this
prospectus, modifies or supersedes such statement. Any statement so modified or superseded shall
not be deemed, except as so
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->5<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">modified or superseded, to constitute a part of this prospectus. This prospectus is part of a
Registration Statement on Form S-8 that we filed with the SEC and does not contain all of the
information set forth in that Registration Statement.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We will provide without charge to each person to whom a copy of this prospectus is delivered,
upon written or oral request of such person, a copy of any or all of the information that has been
incorporated by reference in this prospectus (excluding exhibits, unless such exhibits are
specifically incorporated by reference into the information which this prospectus incorporates).
The mailing address of our principal executive offices is Dex One Corporation, 1001 Winstead Drive,
Cary, N.C., 27513, and our telephone number is (919)&nbsp;297-1600. Written requests for copies of such
information should be directed to Dex One Corporation, 1001 Winstead Drive, Cary, North Carolina
27513, Attention: Investor Relations.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->6<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>PART II</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>INFORMATION REQUIRED IN THE REGISTRATION STATEMENT</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;3. Incorporation of Documents by Reference.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following documents, which are on file with the Commission, are incorporated herein by
reference and made a part hereof:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(a)&nbsp;Annual Report on Form 10-K for the fiscal year ended December&nbsp;31, 2009, filed with the
Commission on March&nbsp;12, 2010;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(b)&nbsp;Quarterly Reports on Form 10-Q for the fiscal quarters ended March&nbsp;31, 2010, filed with
the Commission on May&nbsp;13, 2010, and June&nbsp;30, 2010, filed with the Commission on August&nbsp;11,
2010;
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(c)&nbsp;Current Reports on Form 8-K filed with the Commission on January&nbsp;15, 2010, February&nbsp;4,
2010, May&nbsp;21, 2010, August&nbsp;2, 2010, September&nbsp;9, 2010 and September&nbsp;17, 2010; and
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt; margin-left: 2%">(d)&nbsp;The description of our common stock contained in Item&nbsp;1 of our Registration Statement on
Form 8-A (File No.&nbsp;001-07155) filed with the Commission on January&nbsp;20, 2010 and any
amendments to such Registration Statement filed subsequently thereto, including all
amendments or reports filed for the purpose of updating such description.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as otherwise indicated, all documents we file with the Commission pursuant to Sections
13(a), 13(c), 14, and 15(d) of the Exchange Act (other than Current Reports on Form 8-K furnished
pursuant to Item&nbsp;2.02 or Item&nbsp;7.01 of Form 8-K, including any exhibits included with such
information, unless otherwise indicated therein) subsequent to the date of this prospectus shall be
deemed to be incorporated by reference in this prospectus and to be a part of this prospectus from
the date of filing of such documents.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any statement contained in a previously filed document incorporated by reference in this
prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the
extent that a statement in this prospectus modifies or supersedes such previous statement and any
statement contained in this prospectus shall be deemed to be modified or superseded to the extent
that a statement in any document subsequently filed, which is incorporated by reference in this
prospectus, modifies or supersedes such statement. Any statement so modified or superseded shall
not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;4. Description of Securities.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Not applicable.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;5. Interests of Named Experts and Counsel.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mark W. Hianik, Esq., who has rendered an opinion as to the validity of the Common Stock being
registered by this Registration Statement, is an officer of the Registrant.
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->II-1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;6. Indemnification of Directors and Officers.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dex One Corporation is incorporated under the laws of the state of Delaware. Section&nbsp;145 of
the General Corporation Law of the State of Delaware (the &#147;DGCL&#148;) provides that a Delaware
corporation may indemnify any persons who are, or are threatened to be made, parties to any
threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative, other than an action by or in the right of such corporation, by
reason of the fact that such person is or was an officer, director, employee or agent of such
corporation, or is or was serving at the request of such corporation as a director, officer,
employee or agent of another corporation or enterprise, if such person acted in good faith and in a
manner the person reasonably believed to be in or not opposed to the best interests of the
corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to
believe the person&#146;s conduct was unlawful. Section&nbsp;145 of the DGCL further authorizes a corporation
to purchase and maintain insurance on behalf of any indemnified person against any liability
asserted against him or her and incurred by him or her in any indemnified capacity, or arising out
of his or her status as such, regardless of whether the corporation would otherwise have the power
to indemnify him or her under the DGCL.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In accordance with Section&nbsp;102(b)(7) of the DGCL, Article&nbsp;8 of our certificate of
incorporation provides that directors shall not be personally liable to Dex One Corporation or any
of its stockholders for monetary damages for breach of fiduciary duty as a director, except to the
extent that such exemption from liability or limitation thereof is not permitted by the DGCL as the
same exits or may be amended. If the DGCL is amended to authorize corporate action further limiting
or eliminating the liability of directors, then the liability of a director to Dex One Corporation
or its stockholders shall be limited or eliminated to the full extent permitted by the DGCL, as so
amended.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Article&nbsp;9.A of our certificate of incorporation, we will indemnify and hold
harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter
be amended, any person (an &#147;Indemnified Person&#148;) who was or is made a party or is threatened to be
made a party to or is otherwise involved in any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (a &#147;Proceeding&#148;), by reason of
the fact that such person, or a person for whom such person is the legal representative, is or was
a director or officer of the Company or, while a director or officer of the Company, is or was
serving at the request of the Company as a director, officer, trustee, manager, employee or agent
of another corporation or of a partnership, company, limited liability company, joint venture,
trust, non-profit entity or other enterprise, including service with respect to any employee
benefit plan, whether the basis of such Proceeding is alleged action in an official capacity as a
director or officer or in any other capacity while serving, at the request of the Company, as a
director, officer, employee or agent, against all liability and loss suffered (including judgments,
fines, ERISA excise taxes or penalties and amounts paid in settlement) and expenses (including
attorneys&#146; fees) actually and reasonably incurred by such Indemnified Person in connection with
such Proceeding. Notwithstanding the preceding sentence, the Company shall be required to indemnify
an Indemnified Person in connection with a Proceeding (or part thereof) commenced by such
Indemnified Person only if the commencement of such Proceeding (or part thereof) by the Indemnified
Person was authorized in advance by our board of directors, except for Proceedings brought by an
Indemnified Person to enforce such Indemnified Person&#146;s rights against the Company for
indemnification or advancement of expenses.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to Article&nbsp;9.B of our certificate of incorporation, we shall pay or reimburse (on an
unsecured basis) an Indemnified Person for the reasonable expenses (including attorneys&#146; fees)
actually incurred by such Indemnified Person in connection with any such Proceeding in advance of
its final disposition or final judicial decision (an &#147;advancement of expenses&#148;); provided, however,
that, if and to
the extent required by law, such payment or reimbursement of expenses in advance of the final
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->II-2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">disposition of or final judicial decision regarding the Proceeding shall be made only upon delivery
to the Company of an undertaking, by or on behalf of such Indemnified Person, to repay all amounts
so advanced if it shall ultimately be determined at final disposition or by final judicial decision
from which there is no further right to appeal that such Indemnified Person is not entitled to be
indemnified for such expenses under our certificate of incorporation or otherwise.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The amendment, alteration of repeal of Article&nbsp;8 or Article&nbsp;9 of our certificate of
incorporation requires the affirmative vote of the holders of at least 66 2/3% of the voting power
of then outstanding shares of capital stock of the Company entitled to vote generally in the
election of directors, voting together as a single class.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In addition to the provisions of our certificate of incorporation, Dex One Corporation has
entered into indemnification agreements with all of its directors, to indemnify the directors to
the fullest extent permitted by applicable law (in addition to any indemnification rights provided
in our certificate of incorporation or bylaws). The indemnification agreements also provide that we
will advance to the indemnified director any and all expenses incurred by the indemnified director
within five calendar days after the receipt by the Company of a written request from the
indemnified director for an expense advance, whether prior to or after final disposition of any
Proceeding; provided, however, that, if and to the extent that the DGCL requires, an advancement of
expenses incurred by the indemnified director in his capacity as a director of the Company shall be
made only upon delivery of an undertaking by or on behalf of the indemnified director to repay all
amounts so advanced if it ultimately shall be determined by final judicial decision from which
there is no further right to appeal that the indemnified director is not entitled to be indemnified
for such expenses under the indemnification agreement or otherwise.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As permitted by to Section&nbsp;145 of the DGCL and our certificate of incorporation, Dex One
Corporation also maintains directors and officers insurance to insure such persons against certain
liabilities.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;7. Exemption from Registration Claimed.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All of the shares of common stock that may be offered pursuant to this registration statement
were acquired by the selling stockholder, who is an executive officer and director of Dex One
Corporation, upon the grant of restricted stock pursuant to his Employment Agreement. This grant
was made in reliance upon Section&nbsp;4(2) of the Securities Act, as it did not involve any public
offering and the selling stockholder was an accredited investor within the meaning of Rule&nbsp;501 of
Regulation&nbsp;D under the Securities Act.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;8. Exhibits.</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="89%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Exhibit Name</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of the Company (incorporated by
reference to Exhibit&nbsp;3.1 to the Company&#146;s Current Report on Form&nbsp;8-K filed with
the Securities and Exchange Commission on February&nbsp;4, 2010).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sixth Amended and Restated Bylaws of the Company (incorporated by reference to
Exhibit&nbsp;3.2 to the Company&#146;s Current Report on Form&nbsp;8-K filed with the Securities
and Exchange Commission on February&nbsp;4, 2010).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->II-3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="8%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="89%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000"><B>Exhibit Name</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Mark W. Hianik, Esquire.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employment Agreement, dated September&nbsp;6, 2010, by and between Dex One Corporation
and Alfred Mockett (incorporated by reference to Exhibit&nbsp;10.1 to the Company&#146;s
Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on
September&nbsp;9, 2010).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Independent Registered Public Accounting Firm, KPMG LLP.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Mark W. Hianik, Esquire (included in Exhibit&nbsp;5.1).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top" align="center"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included in the signature page of this Registration Statement).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9. Undertakings.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;The undersigned Registrant hereby undertakes:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1)&nbsp;To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;to include any prospectus required by Section&nbsp;10(a)(3) of the Securities Act;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;to reflect in the prospectus any facts or events arising after the effective date of this
registration statement (or the most recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the information set forth in this registration
statement; and
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;to include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such information in
this registration statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not
apply if the registration statement is on Form S-8, and the information required to be included in
a post-effective amendment by those paragraphs is contained in reports filed with or furnished to
the Commission by the Registrant pursuant to Section&nbsp;13 or Section 15(d) of the Exchange Act that
are incorporated by reference in this registration statement.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2)&nbsp;That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time will be deemed to be
the initial bona fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3)&nbsp;To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;The undersigned Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act, each filing of the Registrant&#146;s annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan&#146;s annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this registration statement will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that
time will be deemed to be the initial bona fide offering thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->II-4<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<DIV align="left" style="font-size: 10pt; margin-top: 6pt">otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->II-5<!-- /Folio -->
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>SIGNATURES</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act, Dex One Corporation certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Cary, North Carolina, on October&nbsp;12, 2010.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left"><B>DEX ONE CORPORATION</B><BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Mark W. Hianik
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Name:&nbsp;&nbsp;</TD>
    <TD align="left">Mark W. Hianik&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top">Title:&nbsp;&nbsp;</TD>
    <TD align="left">Senior Vice President, General Counsel<BR>

and Corporate Secretary&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR>
    <TD colspan="5">&nbsp;</TD>
</TR>
</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>POWER OF ATTORNEY</B>
</DIV>



<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature to this registration
statement appears below hereby constitutes and appoints Mark W. Hianik, Steven M. Blondy and
Gretchen Zech and each of them, as such person&#146;s true and lawful attorneys-in-fact and agents with
full power of substitution for such person and in such person&#146;s name, place and stead, in any and
all capacities, to sign and to file with the Securities and Exchange Commission any and all
amendments and post-effective amendments to this registration statement, with exhibits thereto and
any and all other documents filed in connection with such filings, granting unto each said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes
as such person might or could do in person, hereby ratifying and confirming all that each said
attorney-in-fact and agent, or any substitute therefor, may lawfully do or cause to be done by
virtue thereof.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Signature</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Title</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Date</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Alfred T. Mockett
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>Alfred T. Mockett
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director, President and Chief Executive
Officer<br> (principal executive officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Steven M. Blondy
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Steven M. Blondy
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Executive Vice President and Chief
Financial Officer
<br>(principal financial
officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Sylvester J. Johnson
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
Sylvester J. Johnson
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Vice President &#151; Corporate, Controller and
Chief Accounting Officer <br>(principal accounting officer)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Jonathan B. Bulkeley
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Jonathan B. Bulkeley</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Eugene I. Davis
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Eugene I. Davis</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ W. Kirk Liddell
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">W. Kirk Liddell</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Signature</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Title</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" style="border-bottom: 1px solid #000000">Date</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Richard L. Kuersteiner
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Richard L. Kuersteiner</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mark A. McEachen
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Mark A. McEachen</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Alan F. Schultz
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Director&nbsp;
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">October&nbsp;12, 2010</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Alan F. Schultz</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 18pt"><B>Dex One Corporation</B>
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt"><B>EXHIBIT INDEX<BR>
to<BR>
Form S-8 Registration Statement</B>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="6%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="92%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left"><B>Exhibit</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Number</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Amended and Restated Certificate of Incorporation of the Company (incorporated by
reference to Exhibit&nbsp;3.1 to the Company&#146;s Current Report on Form&nbsp;8-K filed with
the Securities and Exchange Commission on February&nbsp;4, 2010).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">4.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Sixth Amended and Restated Bylaws of the Company (incorporated by reference to
Exhibit&nbsp;3.2 to the Company&#146;s Current Report on Form&nbsp;8-K filed with the Securities
and Exchange Commission on February&nbsp;4, 2010).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">5.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Opinion of Mark W. Hianik, Esquire.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">10.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Employment Agreement, dated September&nbsp;6, 2010, by and between Dex One Corporation
and Alfred Mockett (incorporated by reference to Exhibit&nbsp;10.1 to the Company&#146;s
Current Report on Form&nbsp;8-K filed with the Securities and Exchange Commission on
September&nbsp;9, 2010).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Independent Registered Public Accounting Firm, KPMG LLP.</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">23.2
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Consent of Mark W. Hianik, Esquire (included in Exhibit&nbsp;5.1).</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">24.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Power of Attorney (included in the signature page of this Registration Statement).</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
[{"type": "S-8", "sequence": "1", "filename": "g24853bsv8.htm", "description": "FORM S-8", "secsgml_size_bytes": 96858}]
{"company-data": {"conformed-name": "DEX ONE Corp", "cik": "0000030419", "assigned-sic": "7310", "irs-number": "132740040", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-169875", "film-number": "101119054"}, "business-address": {"street1": "1001 WINSTEAD DRIVE", "city": "CARY", "state": "NC", "zip": "27513", "phone": "9198046000"}, "mail-address": {"street1": "1001 WINSTEAD DRIVE", "city": "CARY", "state": "NC", "zip": "27513"}, "former-company": [{"former-conformed-name": "R H DONNELLEY CORP", "date-changed": "19980716"}, {"former-conformed-name": "DUN & BRADSTREET CORP", "date-changed": "19920703"}, {"former-conformed-name": "DUN & BRADSTREET COMPANIES INC", "date-changed": "19790429"}]}
sv8
As filed with the Securities and Exchange Commission on October 12, 2010.
Registration No. 333-
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
DEX ONE CORPORATION
(Exact name of registrant as specified in its charter)
Delaware
13-2740040
(State or other jurisdiction of incorporation)
(I.R.S. Employer Identification No.)
1001 Winstead Drive, Cary, NC
27513
(Address of principal executive offices)
(zip code)
Employment Agreement with Alfred Mockett
(Full title of the Plan)
Mark W. Hianik
Senior Vice President, General Counsel and Corporate Secretary
Dex One Corporation
1001 Winstead Drive
Cary, NC 27513
(Name and address of agent for service)
(919) 297-1600
(Telephone number, including area code, of agent for service)
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a
non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated
filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.
(Check one):
Large Accelerated Filer
o
Accelerated Filer
o
Non-Accelerated Filer
þ
Smaller Reporting Company
o
(Do not check if a smaller reporting company)
Calculation of Registration Fee
Proposed
Proposed
Title of
maximum
maximum
securities to be
Amount to be
offering price
aggregate
Amount of
registered
registered
(1)
per share
(4)
offering price
(4)
registration fee
Common Stock, par
value $0.001 per
share
200,000
(2)
$10.775
$2,155,000
$153.65
Common Stock, par
value $0.001 per
share
200,000
(3)
$9.75
$1,950,000
$139.00
Common Stock, par
value $0.001 per
share
200,000
(3)
$15.00
$3,000,000
$214.00
Common Stock, par
value $0.001 per
share
200,000
(3)
$23.00
$4,600,000
$328.00
Common Stock, par
value $0.001 per
share
200,000
(3)
$32.00
$6,400,000
$456.00
Total
1,000,000
$18,105,000
$1,290.65
(1)
Pursuant to Rule 416 under the Securities Act of 1933 (the "Securities Act"), this
Registration Statement shall include any additional shares of common stock, par value $0.001 per
share (the "Common Stock"), that may become issuable as a result of stock splits, stock dividends,
recapitalizations or other similar transactions.
(2)
Represents 200,000 shares of our common stock to be issued as restricted stock under the
Employment Agreement with Alfred Mockett ("Employment Agreement").
(3)
Represents 200,000 shares of our common stock underlying stock options currently
outstanding under the Employment Agreement.
(4)
Estimated solely for the purpose of calculating the amount of the registration fee
pursuant to Rule 457(h) under the Securities Act. The price per share and aggregate offering price
are calculated on the basis of (a) $10.775, the average of the high and low sale prices of our
common stock on the New York Stock Exchange on October 8, 2010, in accordance with Rule 457(c)
under the Securities Act, as amended, for 200,000 shares of our common stock to be issued as
restricted stock under the Employment Agreement, (b) $9.75, the exercise price of 200,000 shares of
our common stock underlying outstanding options granted under the Employment Agreement, (c) $15.00,
the exercise price of 200,000 shares of our common stock underlying outstanding options granted
under the Employment Agreement, (d) $23.00, the exercise price of 200,000 shares of our common
stock underlying outstanding options granted under the Employment Agreement, and (e) $32.00, the
exercise price of 200,000 shares of our common stock underlying outstanding options granted under
the Employment Agreement.
PART I
INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
Item 1. Plan Information
Dex One Corporation ("we", "us", "the Company" or "Dex One") entered into an employment
agreement with Alfred T. Mockett on September 6, 2010 (the "Employment Agreement"). The documents
containing the information specified in Part I will be delivered in accordance with Form S-8 and
Rule 428(b) under the Securities Act. Such documents are not required to be, and are not, filed
with the Securities and Exchange Commission (the "Commission"), either as part of this Registration
Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities
Act. These documents, and the documents incorporated by reference in this Registration Statement
pursuant to Item 3 of Part II of this Form S-8, taken together, constitute a prospectus that meets
the requirements of Section 10(a) of the Securities Act.
Item 2. Registrant Information and Employee Plan Annual Information.
The written statement required by Item 2 of Part I will be included in documents to be
delivered to Mr. Mockett pursuant to Rule 428(b) of the Securities Act.
I-1
REOFFER PROSPECTUS
DEX ONE CORPORATION
200,000 SHARES OF COMMON STOCK
This prospectus relates to the resale, from time to time, of up to 200,000 shares of our
common stock, $0.001 par value per share, by the selling stockholder listed in this prospectus. The
selling stockholder acquired such shares pursuant to grants made under the employment agreement
dated as of September 6, 2010, between Dex One Corporation and Alfred T. Mockett (the "Employment
Agreement").
The shares may be offered, from time to time, by the selling stockholder through ordinary
brokerage transactions, in negotiated transactions or in other transactions, at such prices as he
may determine, which may relate to market prices prevailing at the time of sale or be a negotiated
price. See "Plan of Distribution." We will bear all costs, expenses and fees in connection with the
registration of the shares. Brokerage commissions and similar selling expenses, if any,
attributable to the offer or sale of the shares will be borne by the selling stockholder.
We will not receive any proceeds from sales of the shares of our common stock covered by this
prospectus by the selling stockholder.
The selling stockholder and any broker executing selling orders on behalf of the selling
stockholder may be deemed to be an "underwriter" as defined in the Securities Act of 1933, as
amended (the "Securities Act"). If any broker-dealers are used to effect sales, any commissions
paid to broker-dealers and, if broker-dealers purchase any of the shares of common stock covered by this
prospectus as principals, any profits received by such broker-dealers on the resales of shares may
be deemed to be underwriting discounts or commissions under the Securities Act. In addition, any
profits realized by the selling stockholder may be deemed to be underwriting commissions.
Shares of our common stock are listed on the New York Stock Exchange under the symbol "DEXO."
On October 8, 2010, the last reported sale price of our common stock was $10.98 per share.
Investing in shares of our common stock involves a high degree of risk. See "Risk Factors" on
page 2 of this prospectus and the other risk factors set forth in our periodic and other filings
with the Securities and Exchange Commission (the "SEC"), including those set forth in our Annual
Report on
Form 10-K
for the year ended December 31, 2009, for a discussion of certain factors that
should carefully be considered by prospective purchasers.
Neither the SEC nor any state securities commission has approved or disapproved of these
securities or determined if this prospectus is truthful or complete. Any representation to the
contrary is a criminal offense.
This prospectus is dated October 12, 2010.
TABLE OF CONTENTS
Page
Prospectus Summary
1
Forward-Looking Statements
1
Risk Factors
2
Use of Proceeds
2
Selling Stockholder
2
Plan of Distribution
4
Legal Matters
4
Experts
4
Available Information
5
Information Incorporated by Reference
5
You should rely only on the information contained in or incorporated by reference into this
prospectus. We have not authorized any other person to provide you with additional information or
information different from that contained in or incorporated by reference into this prospectus. The
selling
stockholder may, from time to time, offer to sell shares of our common stock only in jurisdictions
where the offer or sale is permitted. You should not assume that the information contained in this
prospectus is accurate as of any date other than the date on the front cover of this prospectus or
that the information contained in any document incorporated by reference into this prospectus is
accurate as of any date other than the date of the document incorporated by reference.
PROSPECTUS SUMMARY
This summary highlights information contained elsewhere in or incorporated by reference into
this prospectus. This summary is not complete and does not contain all of the information that may
be important to you and that you should consider before investing in shares of our common stock.
You should carefully read the entire prospectus, including the section titled "Risk Factors," and
the other information incorporated by reference into this prospectus before making an investment
decision.
References in this prospectus to the terms "Dex,"Dex One," "the Company," "we," "us" and "our," or
other similar terms, mean Dex One Corporation, together with its consolidated subsidiaries, unless
the context indicates otherwise.
Dex One Corporation
We are a marketing solutions company that helps local businesses grow by providing marketing
products that help them get found by ready-to-buy consumers and marketing services that help them
get chosen over their competitors. Through our Dex
®
Advantage, clients' business information is
published and marketed through a single profile and distributed via a variety of both owned and
operated products and through other local search products. Dex Advantage spans multiple media
platforms for local advertisers including print with our Dex published directories, which we
co-brand with other brands in the industry such as Qwest, CenturyLink and AT&T, online and mobile
devices with DexKnows.com
®
and voice-activated directory search at 1-800-Call-Dex™. Our digital
affiliate provided solutions are powered by DexNet™, which leverages network partners including the
premier search engines, such as Google
®
and Yahoo!
®
and other leading online sites. Our growing
list of marketing services include local business and market analysis, message and image creation,
target market identification, advertising and digital profile creation, keyword and search engine
optimization strategies and programs, distribution strategies, social strategies, and tracking and
reporting.
Our principal executive offices are located at 1001 Winstead Drive, Cary, North Carolina
27513, our telephone number is (919) 297-1600 and our website address is www.dexone.com.
Information contained on our website is not a part of this prospectus.
FORWARD-LOOKING STATEMENTS
Certain statements contained or incorporated by reference in this Registration Statement on
Form S-8 regarding Dex One's future operating results, performance, business plans or prospects and
any other statements not constituting historical fact are "forward-looking statements" subject to
the safe harbor created by the Private Securities Litigation Reform Act of 1995. Where possible,
words such as "believe," "expect," "anticipate," "should," "will," "would," "planned," "estimated,"
"potential," "goal," "outlook," "may," "predicts," "could," or the negative of those words and
other comparable expressions, are used to identify such forward-looking statements. All
forward-looking statements reflect our current beliefs and assumptions with respect to our future
results, business plans and prospects, based on information currently available to us and are
subject to significant risks and uncertainties. Accordingly, these statements are subject to
significant risks and uncertainties and our actual results, business plans and prospects could
differ significantly from those expressed in, or implied by, these statements. We caution readers
not to place undue reliance on, and we undertake no obligation to update, other than as imposed by
law, any forward-looking statements. Such risks, uncertainties and contingencies include, but are
not limited to, statements about Dex One's future financial and operating results, our plans,
objectives, expectations and intentions and other statements that are not historical facts. The
following factors, among others, could cause actual results to differ from those set forth in the
forward-looking statements: (1) changes in directory advertising spend and consumer usage; (2)
competition and other economic
1
conditions; (3) our ability to generate sufficient cash to service our debt; (4) our
ability to comply with the financial covenants contained in our debt agreements and the potential
impact to operations and liquidity as a result of restrictive covenants in such debt agreements;
(5) our ability to refinance or restructure our debt on reasonable terms and conditions as might be
necessary from time to time; (6) increasing LIBOR rates; (7) regulatory and judicial rulings; (8)
changes in the Company's and the Company's subsidiaries credit ratings; (9) changes in accounting
standards; (10) adverse results from litigation, governmental investigations or tax related
proceedings or audits; (11) the effect of labor strikes, lock-outs and negotiations; (12)
successful realization of the expected benefits of acquisitions, divestitures and joint ventures;
(13) the continued enforceability of the commercial agreements with Qwest, CenturyLink and AT&T;
(14) our reliance on third-party vendors for various services; and (15) other events beyond our
control that may result in unexpected adverse operating results. Additional risks and uncertainties
are described in detail in Part I — Item 1A, "Risk Factors" of our most recent annual report on
Form 10-K.
RISK FACTORS
Our business is subject to uncertainties and risks. You should carefully consider and evaluate
all of the information included and incorporated by reference in this prospectus, including the
risk factors incorporated by reference from our most recent annual report on Form 10-K, as updated
by our subsequent quarterly reports on Form 10-Q and other filings we make with the SEC. It is
possible that our business, financial condition, liquidity or results of operations could be
materially adversely affected by any of these risks.
USE OF PROCEEDS
We will not receive any of the proceeds from the sale of the shares offered by this
prospectus.
We will pay all expenses in connection with the registration of shares, other than commissions
and discounts of underwriters, dealers or agents.
SELLING STOCKHOLDER
The shares offered by this prospectus are being registered for reoffers and resales by the
selling stockholder, who has acquired such shares pursuant to a grant of restricted stock. The
selling stockholder named below may resell all, a portion or none of such shares from time to time.
The table below sets forth, with respect to the selling stockholder, based upon information
available to us as of October 8, 2010, the number of shares of common stock beneficially owned
before and after the sale of the shares offered by this prospectus; the number of shares to be
sold; and the percent of the outstanding shares of common stock owned before and after the sale of the common
stock offered by this prospectus.
Number of
Percentage
Number of
Percentage
Number of
Shares Owned
of Shares
Shares
of Shares
Shares to
After
Owned After
Selling Stockholder
Owned
(1)
Owned
be Offered
Offering
(2)
Offering
(2)
Alfred T. Mockett
200,000
*
200,000
0
0
%
(Chief Executive
Officer and
President)
2
*
Represents less than 1% of the issued and outstanding common stock.
(1)
Dex One Corporation and Alfred T. Mockett are parties to an employment agreement dated as of
September 6, 2010, pursuant to which we agreed to employ Mr. Mockett as our Chief Executive
Officer and President. Pursuant to this agreement, Mr. Mockett was granted 200,000 shares of
the Company's common stock in the form of a restricted stock award, a fair market value option
to purchase 200,000 shares of the Company's common stock, and fully vested premium priced
options to purchase 600,000 shares of the Company's common stock. The 200,000 share restricted
stock award vests in three equal annual installments on each anniversary of September 13,
2010. This summary of Mr. Mockett's employment agreement is qualified in its entirety by
reference to Current Report on Form 8-K filed by us on September 9, 2010.
(2)
Assumes that the selling stockholder disposes of all the shares of common stock covered by
this prospectus, and does not acquire beneficial ownership of any additional shares. The
registration of these shares does not necessarily mean that the selling stockholder will sell all
or any portion of the shares covered by this prospectus.
3
PLAN OF DISTRIBUTION
The shares may be sold or transferred for value by the selling stockholder, or by pledgees,
donees, transferees or other successors in interest to the selling stockholder, in one or more
transactions on the New York Stock Exchange, in negotiated transactions or in a combination of such
methods of sale, at market prices prevailing at the time of sale, at prices related to such
prevailing market prices or at prices otherwise negotiated. The selling stockholder may effect such
transactions by selling the shares to or through broker-dealers, and such broker-dealers may
receive compensation in the form of underwriting discounts, concessions or commissions from the
selling stockholder and/or the purchasers of the shares for whom such broker-dealers may act as
agent (which compensation may be less than or in excess of customary commissions). The selling
stockholder, and any broker-dealers that participate in the distribution of the shares, may be
deemed to be "underwriters" within the meaning of Section 2(11) of the Securities Act, and any
commissions received by them and any profit on the resale of the shares sold by them may be deemed
to be underwriting discounts and commissions under the Securities Act. All
selling and other expenses incurred by individual selling stockholder will be borne by the selling
stockholder.
Upon our being notified by the selling stockholder that any material arrangement has been
entered into with a broker or dealer for the sale of shares through a secondary distribution, or a
purchase by a broker or dealer, we will file a prospectus supplement, if required, pursuant to Rule
424(b) under the
Securities Act, disclosing (a) the name of each of such selling stockholder and the participating
broker-dealers, (b) the number of shares involved, (c) the price at which such shares are being
sold, (d) the commissions paid or the discounts or concessions allowed to such broker-dealers, (e)
where applicable, that such broker-dealers did not conduct any investigation to verify the
information set out or incorporated by reference in the prospectus, as supplemented, and (f) other
facts material to the transaction.
In addition to any such number of shares sold hereunder, the selling stockholder may, at the
same time, sell any shares of common stock, including the shares offered by this prospectus, owned
by such person in compliance with all of the requirements of Rule 144 under the Securities Act,
regardless of
whether such shares are covered by this prospectus.
There is no assurance that the selling stockholder will sell any or all of the shares offered
by this prospectus.
LEGAL MATTERS
The validity of the shares of common stock offered by this prospectus has been passed upon for
Dex One by Mark W. Hianik, the Company's General Counsel.
EXPERTS
The consolidated financial statements of R.H. Donnelley Corporation (the predecessor to Dex
One) and subsidiaries as of December 31, 2009 and 2008 and for each of the years in the three year
period ended December 31, 2009 and management's assessment of the effectiveness of internal control
over financial reporting, which is included in Management's Report on Internal Control over
Financial Reporting, have been incorporated in this Prospectus by reference to the Annual Report on
Form 10-K for the year ended December 31, 2009 in reliance upon the reports of KPMG LLP,
independent registered public accounting firm, incorporated by reference herein, and upon the
authority of said firm as experts in accounting and auditing.
4
AVAILABLE INFORMATION
We file annual, quarterly and current reports, proxy statements and other information with the
Commission. You may read and copy any reports, statements or other information that we file with
the Commission at the Commission's Public Reference Room located at 100 F Street, N.E., Washington,
D.C. 20549. Please call the Commission at l-800-SEC-0330 for further information about the
operation of the Public Reference Room. Our public filings are also available from commercial
document retrieval services and at the Internet web site maintained by the Commission at
http://www.sec.gov. We distribute to our stockholders annual reports containing audited financial
statements.
DOCUMENTS INCORPORATED BY REFERENCE
The Commission allows us to "incorporate by reference" information into this prospectus, which
means that we can disclose important information to investors by referring them to another document
filed separately with the Commission. The information incorporated by reference is deemed to be
part of
this prospectus, except for any information superseded by information contained directly in this
document. This prospectus incorporates by reference the documents set forth below that we have
previously filed with the Commission. These documents contain important information about us and
our financial condition.
We incorporate by reference the documents listed below:
(a) Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the
Commission on March 12, 2010;
(b) Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2010, filed with
the Commission on May 13, 2010, and June 30, 2010, filed with the Commission on August 11,
2010;
(c) Current Reports on Form 8-K filed with the Commission on January 15, 2010, February 4,
2010, May 21, 2010, August 2, 2010, September 9, 2010 and September 17, 2010; and
(d) The description of our common stock contained in Item 1 of our Registration Statement on
Form 8-A (File No. 001-07155) filed with the Commission on January 20, 2010 and any
amendments to such Registration Statement filed subsequently thereto, including all
amendments or reports filed for the purpose of updating such description.
Except as otherwise indicated, all documents we file with the Commission pursuant to Sections
13(a), 13(c), 14, and 15(d) of the Exchange Act (other than Current Reports on Form 8-K furnished
pursuant to Item 2.02 or Item 7.01 of Form 8-K, including any exhibits included with such
information, unless otherwise indicated therein) subsequent to the date of this prospectus shall be
deemed to be incorporated by reference in this prospectus and to be a part of this prospectus from
the date of filing of such documents.
Any statement contained in a previously filed document incorporated by reference in this
prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the
extent that a statement in this prospectus modifies or supersedes such previous statement and any
statement contained in this prospectus shall be deemed to be modified or superseded to the extent
that a statement in any document subsequently filed, which is incorporated by reference in this
prospectus, modifies or supersedes such statement. Any statement so modified or superseded shall
not be deemed, except as so
5
modified or superseded, to constitute a part of this prospectus. This prospectus is part of a
Registration Statement on Form S-8 that we filed with the SEC and does not contain all of the
information set forth in that Registration Statement.
We will provide without charge to each person to whom a copy of this prospectus is delivered,
upon written or oral request of such person, a copy of any or all of the information that has been
incorporated by reference in this prospectus (excluding exhibits, unless such exhibits are
specifically incorporated by reference into the information which this prospectus incorporates).
The mailing address of our principal executive offices is Dex One Corporation, 1001 Winstead Drive,
Cary, N.C., 27513, and our telephone number is (919) 297-1600. Written requests for copies of such
information should be directed to Dex One Corporation, 1001 Winstead Drive, Cary, North Carolina
27513, Attention: Investor Relations.
6
PART II
INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
Item 3. Incorporation of Documents by Reference.
The following documents, which are on file with the Commission, are incorporated herein by
reference and made a part hereof:
(a) Annual Report on Form 10-K for the fiscal year ended December 31, 2009, filed with the
Commission on March 12, 2010;
(b) Quarterly Reports on Form 10-Q for the fiscal quarters ended March 31, 2010, filed with
the Commission on May 13, 2010, and June 30, 2010, filed with the Commission on August 11,
2010;
(c) Current Reports on Form 8-K filed with the Commission on January 15, 2010, February 4,
2010, May 21, 2010, August 2, 2010, September 9, 2010 and September 17, 2010; and
(d) The description of our common stock contained in Item 1 of our Registration Statement on
Form 8-A (File No. 001-07155) filed with the Commission on January 20, 2010 and any
amendments to such Registration Statement filed subsequently thereto, including all
amendments or reports filed for the purpose of updating such description.
Except as otherwise indicated, all documents we file with the Commission pursuant to Sections
13(a), 13(c), 14, and 15(d) of the Exchange Act (other than Current Reports on Form 8-K furnished
pursuant to Item 2.02 or Item 7.01 of Form 8-K, including any exhibits included with such
information, unless otherwise indicated therein) subsequent to the date of this prospectus shall be
deemed to be incorporated by reference in this prospectus and to be a part of this prospectus from
the date of filing of such documents.
Any statement contained in a previously filed document incorporated by reference in this
prospectus shall be deemed to be modified or superseded for purposes of this prospectus to the
extent that a statement in this prospectus modifies or supersedes such previous statement and any
statement contained in this prospectus shall be deemed to be modified or superseded to the extent
that a statement in any document subsequently filed, which is incorporated by reference in this
prospectus, modifies or supersedes such statement. Any statement so modified or superseded shall
not be deemed, except as so modified or superseded, to constitute a part of this prospectus.
Item 4. Description of Securities.
Not applicable.
Item 5. Interests of Named Experts and Counsel.
Mark W. Hianik, Esq., who has rendered an opinion as to the validity of the Common Stock being
registered by this Registration Statement, is an officer of the Registrant.
II-1
Item 6. Indemnification of Directors and Officers.
Dex One Corporation is incorporated under the laws of the state of Delaware. Section 145 of
the General Corporation Law of the State of Delaware (the "DGCL") provides that a Delaware
corporation may indemnify any persons who are, or are threatened to be made, parties to any
threatened, pending or completed action, suit or proceeding, whether civil, criminal,
administrative or investigative, other than an action by or in the right of such corporation, by
reason of the fact that such person is or was an officer, director, employee or agent of such
corporation, or is or was serving at the request of such corporation as a director, officer,
employee or agent of another corporation or enterprise, if such person acted in good faith and in a
manner the person reasonably believed to be in or not opposed to the best interests of the
corporation, and, with respect to any criminal action or proceeding, had no reasonable cause to
believe the person's conduct was unlawful. Section 145 of the DGCL further authorizes a corporation
to purchase and maintain insurance on behalf of any indemnified person against any liability
asserted against him or her and incurred by him or her in any indemnified capacity, or arising out
of his or her status as such, regardless of whether the corporation would otherwise have the power
to indemnify him or her under the DGCL.
In accordance with Section 102(b)(7) of the DGCL, Article 8 of our certificate of
incorporation provides that directors shall not be personally liable to Dex One Corporation or any
of its stockholders for monetary damages for breach of fiduciary duty as a director, except to the
extent that such exemption from liability or limitation thereof is not permitted by the DGCL as the
same exits or may be amended. If the DGCL is amended to authorize corporate action further limiting
or eliminating the liability of directors, then the liability of a director to Dex One Corporation
or its stockholders shall be limited or eliminated to the full extent permitted by the DGCL, as so
amended.
Pursuant to Article 9.A of our certificate of incorporation, we will indemnify and hold
harmless, to the fullest extent permitted by applicable law as it presently exists or may hereafter
be amended, any person (an "Indemnified Person") who was or is made a party or is threatened to be
made a party to or is otherwise involved in any threatened, pending or completed action, suit or
proceeding, whether civil, criminal, administrative or investigative (a "Proceeding"), by reason of
the fact that such person, or a person for whom such person is the legal representative, is or was
a director or officer of the Company or, while a director or officer of the Company, is or was
serving at the request of the Company as a director, officer, trustee, manager, employee or agent
of another corporation or of a partnership, company, limited liability company, joint venture,
trust, non-profit entity or other enterprise, including service with respect to any employee
benefit plan, whether the basis of such Proceeding is alleged action in an official capacity as a
director or officer or in any other capacity while serving, at the request of the Company, as a
director, officer, employee or agent, against all liability and loss suffered (including judgments,
fines, ERISA excise taxes or penalties and amounts paid in settlement) and expenses (including
attorneys' fees) actually and reasonably incurred by such Indemnified Person in connection with
such Proceeding. Notwithstanding the preceding sentence, the Company shall be required to indemnify
an Indemnified Person in connection with a Proceeding (or part thereof) commenced by such
Indemnified Person only if the commencement of such Proceeding (or part thereof) by the Indemnified
Person was authorized in advance by our board of directors, except for Proceedings brought by an
Indemnified Person to enforce such Indemnified Person's rights against the Company for
indemnification or advancement of expenses.
Pursuant to Article 9.B of our certificate of incorporation, we shall pay or reimburse (on an
unsecured basis) an Indemnified Person for the reasonable expenses (including attorneys' fees)
actually incurred by such Indemnified Person in connection with any such Proceeding in advance of
its final disposition or final judicial decision (an "advancement of expenses"); provided, however,
that, if and to
the extent required by law, such payment or reimbursement of expenses in advance of the final
II-2
disposition of or final judicial decision regarding the Proceeding shall be made only upon delivery
to the Company of an undertaking, by or on behalf of such Indemnified Person, to repay all amounts
so advanced if it shall ultimately be determined at final disposition or by final judicial decision
from which there is no further right to appeal that such Indemnified Person is not entitled to be
indemnified for such expenses under our certificate of incorporation or otherwise.
The amendment, alteration of repeal of Article 8 or Article 9 of our certificate of
incorporation requires the affirmative vote of the holders of at least 66 2/3% of the voting power
of then outstanding shares of capital stock of the Company entitled to vote generally in the
election of directors, voting together as a single class.
In addition to the provisions of our certificate of incorporation, Dex One Corporation has
entered into indemnification agreements with all of its directors, to indemnify the directors to
the fullest extent permitted by applicable law (in addition to any indemnification rights provided
in our certificate of incorporation or bylaws). The indemnification agreements also provide that we
will advance to the indemnified director any and all expenses incurred by the indemnified director
within five calendar days after the receipt by the Company of a written request from the
indemnified director for an expense advance, whether prior to or after final disposition of any
Proceeding; provided, however, that, if and to the extent that the DGCL requires, an advancement of
expenses incurred by the indemnified director in his capacity as a director of the Company shall be
made only upon delivery of an undertaking by or on behalf of the indemnified director to repay all
amounts so advanced if it ultimately shall be determined by final judicial decision from which
there is no further right to appeal that the indemnified director is not entitled to be indemnified
for such expenses under the indemnification agreement or otherwise.
As permitted by to Section 145 of the DGCL and our certificate of incorporation, Dex One
Corporation also maintains directors and officers insurance to insure such persons against certain
liabilities.
Item 7. Exemption from Registration Claimed.
All of the shares of common stock that may be offered pursuant to this registration statement
were acquired by the selling stockholder, who is an executive officer and director of Dex One
Corporation, upon the grant of restricted stock pursuant to his Employment Agreement. This grant
was made in reliance upon Section 4(2) of the Securities Act, as it did not involve any public
offering and the selling stockholder was an accredited investor within the meaning of Rule 501 of
Regulation D under the Securities Act.
Item 8. Exhibits.
Exhibit Number
Exhibit Name
4.1
Amended and Restated Certificate of Incorporation of the Company (incorporated by
reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with
the Securities and Exchange Commission on February 4, 2010).
4.2
Sixth Amended and Restated Bylaws of the Company (incorporated by reference to
Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the Securities
and Exchange Commission on February 4, 2010).
II-3
Exhibit Number
Exhibit Name
5.1
Opinion of Mark W. Hianik, Esquire.
10.1
Employment Agreement, dated September 6, 2010, by and between Dex One Corporation
and Alfred Mockett (incorporated by reference to Exhibit 10.1 to the Company's
Current Report on Form 8-K filed with the Securities and Exchange Commission on
September 9, 2010).
23.1
Consent of Independent Registered Public Accounting Firm, KPMG LLP.
23.2
Consent of Mark W. Hianik, Esquire (included in Exhibit 5.1).
24.1
Power of Attorney (included in the signature page of this Registration Statement).
Item 9. Undertakings.
(a) The undersigned Registrant hereby undertakes:
(1) To file, during any period in which offers or sales are being made, a post-effective
amendment to this registration statement:
(i) to include any prospectus required by Section 10(a)(3) of the Securities Act;
(ii) to reflect in the prospectus any facts or events arising after the effective date of this
registration statement (or the most recent post-effective amendment thereof) which, individually or
in the aggregate, represent a fundamental change in the information set forth in this registration
statement; and
(iii) to include any material information with respect to the plan of distribution not
previously disclosed in this registration statement or any material change to such information in
this registration statement; provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not
apply if the registration statement is on Form S-8, and the information required to be included in
a post-effective amendment by those paragraphs is contained in reports filed with or furnished to
the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that
are incorporated by reference in this registration statement.
(2) That, for the purpose of determining any liability under the Securities Act, each such
post-effective amendment shall be deemed to be a new registration statement relating to the
securities offered therein, and the offering of such securities at that time will be deemed to be
the initial bona fide offering thereof.
(3) To remove from registration by means of a post-effective amendment any of the securities
being registered which remain unsold at the termination of the offering.
(b) The undersigned Registrant hereby undertakes that, for purposes of determining any
liability under the Securities Act, each filing of the Registrant's annual report pursuant to
Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an
employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is
incorporated by reference in this registration statement will be deemed to be a new registration
statement relating to the securities offered therein, and the offering of such securities at that
time will be deemed to be the initial bona fide offering thereof.
(c) Insofar as indemnification for liabilities arising under the Securities Act may be
permitted to directors, officers and controlling persons of the Registrant pursuant to the
foregoing provisions, or
II-4
otherwise, the Registrant has been advised that in the opinion of the
Commission such indemnification is against public policy as expressed in the Securities Act and is,
therefore, unenforceable. In the event that a claim for indemnification against such liabilities
(other than the payment by the Registrant of expenses incurred or paid by a director, officer or
controlling person of the Registrant in the successful defense of any action, suit or proceeding)
is asserted by such director, officer or controlling person in connection with the securities being
registered, the Registrant will, unless in the opinion of its counsel the matter has been settled
by controlling precedent, submit to a court of appropriate jurisdiction the question whether such
indemnification by it is against public policy as expressed in the Securities Act and will be
governed by the final adjudication of such issue.
II-5
SIGNATURES
Pursuant to the requirements of the Securities Act, Dex One Corporation certifies that it has
reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has
duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto
duly authorized, in Cary, North Carolina, on October 12, 2010.
DEX ONE CORPORATION
By:
/s/ Mark W. Hianik
Name:
Mark W. Hianik
Title:
Senior Vice President, General Counsel
and Corporate Secretary
POWER OF ATTORNEY
KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature to this registration
statement appears below hereby constitutes and appoints Mark W. Hianik, Steven M. Blondy and
Gretchen Zech and each of them, as such person's true and lawful attorneys-in-fact and agents with
full power of substitution for such person and in such person's name, place and stead, in any and
all capacities, to sign and to file with the Securities and Exchange Commission any and all
amendments and post-effective amendments to this registration statement, with exhibits thereto and
any and all other documents filed in connection with such filings, granting unto each said
attorney-in-fact and agent full power and authority to do and perform each and every act and thing
requisite and necessary to be done in and about the premises, as fully to all intents and purposes
as such person might or could do in person, hereby ratifying and confirming all that each said
attorney-in-fact and agent, or any substitute therefor, may lawfully do or cause to be done by
virtue thereof.
Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated.
Signature
Title
Date
/s/ Alfred T. Mockett
Alfred T. Mockett
Director, President and Chief Executive
Officer
(principal executive officer)
October 12, 2010
/s/ Steven M. Blondy
Steven M. Blondy
Executive Vice President and Chief
Financial Officer
(principal financial
officer)
October 12, 2010
/s/ Sylvester J. Johnson
Sylvester J. Johnson
Vice President — Corporate, Controller and
Chief Accounting Officer
(principal accounting officer)
October 12, 2010
/s/ Jonathan B. Bulkeley
Director
October 12, 2010
Jonathan B. Bulkeley
/s/ Eugene I. Davis
Director
October 12, 2010
Eugene I. Davis
/s/ W. Kirk Liddell
Director
October 12, 2010
W. Kirk Liddell
Signature
Title
Date
/s/ Richard L. Kuersteiner
Director
October 12, 2010
Richard L. Kuersteiner
/s/ Mark A. McEachen
Director
October 12, 2010
Mark A. McEachen
/s/ Alan F. Schultz
Director
October 12, 2010
Alan F. Schultz
Dex One Corporation
EXHIBIT INDEX
to
Form S-8 Registration Statement
Exhibit
Number
Description
4.1
Amended and Restated Certificate of Incorporation of the Company (incorporated by
reference to Exhibit 3.1 to the Company's Current Report on Form 8-K filed with
the Securities and Exchange Commission on February 4, 2010).
4.2
Sixth Amended and Restated Bylaws of the Company (incorporated by reference to
Exhibit 3.2 to the Company's Current Report on Form 8-K filed with the Securities
and Exchange Commission on February 4, 2010).
5.1
Opinion of Mark W. Hianik, Esquire.
10.1
Employment Agreement, dated September 6, 2010, by and between Dex One Corporation
and Alfred Mockett (incorporated by reference to Exhibit 10.1 to the Company's
Current Report on Form 8-K filed with the Securities and Exchange Commission on
September 9, 2010).
23.1
Consent of Independent Registered Public Accounting Firm, KPMG LLP.
23.2
Consent of Mark W. Hianik, Esquire (included in Exhibit 5.1).
24.1
Power of Attorney (included in the signature page of this Registration Statement).